Design and synthesis of a novel series of nonpeptidic HIV-1 protease inhibitors

Pharmacy and Pharmacology Communications

Volumn 4, Issue 8, 1998, Pages 365-372

  Hariprasad, V ^a   Talele, T T ^a   Kulkarni, Vithal M ^a  

^a UNIVERSITY OF MUMBAI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1 (NAPHTHOXYACETYL)HISTIDYL(5 AMINO 6 CYCLOHEXYL 3,4 DIHYDROXY 2 ISOPROPYLHEXANOYL)ISOLEUCINE N (2 PYRIDYLMETHYL)AMIDE; 4 HYDROXYCOUMARIN DERIVATIVE; BENZOPYRAN DERIVATIVE; PHENPROCOUMON; PROTEINASE INHIBITOR; WARFARIN;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG SYNTHESIS; MOLECULAR DYNAMICS; MOLECULAR MODEL;

EID: 0031662516     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Abraham, M. H., Duce, P. P., Prior, D. V., Barratt, D. G., Morris, J. J., Taylor, P. J. (1989) Hydrogen bonding. Part 9. Solute donor and acceptor scales for use in drug design. J. Chem. Soc., Perkin Trans. II: 1355-1375
2. Chen, X., Tropsha, A. (1995) Relative binding free energies of peptide inhibitors of HIV-1 protease: the influence of the active site protonation state. J. Med. Chem. 38: 42-48
3. Gupta, S. C., Saini, A., Kumar, D., Yadav, N. S., Chand, K., Mor, S., Dhawan, S. N. (1995) On the mechanism for the photo transformation of 3-Alkoxy-2-(2′-furyl)4-oxo-4H-benzopyrans. J. Chem. Soc., Perkin Trans. I: 177-181
4. Hariprasad, V., Kulkarni, V. M. (1996) A molecular dynamics study of the three-dimensional model of human syanovial fluid phospholipase A2 - transition state mimic complexes. J. Mol. Recogn. 9: 95-102
5. Hariprasad, V., Kulkarni, V. M. (1997) Docking of a series of peptide-based interleukin-1β converting enzyme inhibitors with aspartyl hemiacetals, α-(2,6-dichlorobenzoyl)oxy)-methyl and (acyloxy)methyl ketone moieties. J. Mol. Model. 3: 443-454
6. Lunney, E. A., Hagen, S. E., Domagala, J. M., Humblet, C., Kosinski, J., Tait, B. D., Warmus, J. S., Wilson, M., Ferguson, D., Hupe, D., Tummino, P. J., Baldwin, E. T., Bhat, T. N., Liu, B., Erickson, J. W. (1994) A novel nonpeptide HIV-1 protease inhibitors: elucidation of the binding mode and its application in the design of related analogs. J. Med. Chem. 37: 2664-2677
7. Matayoshi, E. D., Wang, G. T., Kraft, G. A., Erickson, J. W. (1990) Novel fluorogenic substrate retroviral protease by resonance energy transfer. Science 247: 954-958
8. Schechter, I., Berger, A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27: 157-162
9. Singh, O. V., Garg, C. P., Kapoor, R. P., Aruna, K., Nalini, M. (1992) Synthesis and anticomplementary activity of 2-(2-aryl-3-alkoxychromon-6-yl)propanoic acids. Indian J. Chem. 31B: 248-253
10. Thaisrivongs, S., Tomasselli, A. G., Moon, J. B., Hui, J., McQuade, T. J., Turner, S. R., Strohbach, J. W., Howe, J. W., Tarpley, W. G., Heinrikson, R. L. (1991) Inhibitors of the protease from human immunodeficiency virus: design and modeling of compound containing a dihydroxy ethylene isostere insert with high binding affinity and effective antiviral activity. J. Med. Chem. 34: 2344-2356
11. Tummino, P. J., Ferguson, D., Hupe, L., Hupe, D. (1994) Competitive inhibition of HIV-1 protease by 4-hydroxy- benzopyran-2-ones and by 4-hydroxy-6-phenylpyran-2-ones. Biochem. Biophys. Res. Commun. 200: 1658-1664
12. Ukita, T., Nojima, S., Matsumoto, M. (1950) The antibacterial properties of compounds containing the tricarbonylmethane group. IV. Synthesis of 3-alkylated 4-hydroxycoumarins and of a related pyrone. J. Am. Chem. Soc. 72: 5143-5144
13. Vara Prasad, J. V. N., Par, K. S., Lunney, E. A., Ortwine, D. F., Dunbar, J. B., Ferguson, D., Tummino, P. J., Hupe, D., Tait, B. D., Domagala, J. M., Humblet, C., Bhat, T. N., Liu, B., Guerin, D. M. A., Baldwin, E. T., Erickson, J. W., Sawyer, T. K. (1994) Novel series of achiral, low molecular weight, and potent HIV-1 protease inhibitors. J. Am. Chem. Soc. 116: 6989-6990
14. 2′ subsite in a unique mode of active site binding. J. Med. Chem. 38: 898-905
15. Weislow, O. W., Kiser, R., Fine, D., Bader, J., Shoemaker, R. H., Boyd, M. R. (1989) New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl Cancer Inst. 81: 577-586
16. Yamazaki, T., Nicholson, L. K., Torchia, D. A., Wingfield, P., Stahl, S. J., Kaufman, J. D., Eyermann, C. J., Hodge, C. N., Lam, P. Y. S., Ru, Y., Jadhav, P. K., Chang, C. -H., Weber, P. C. (1994) NMR and X-ray evidence that HIV protease catalytic aspartyl groups protonated in the complex formed by the protease and a nonpeptide cyclic urea-based inhibitor. J. Am. Chem. Soc. 116: 10791